1. American Cancer Society. Cancer Facts and Figures. Available at: http://www.cancer.org/docroot/stt/stt_0.asp. Accessed July 9, 2008.
2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, version 1. Available at: http://www.nccn.org. Accessed July 9, 2008.
3. United States Food and Drug Administration. FDA approves Campostar for first line therapy in treatment of advanced colorectal cancer. Available at: http://www.fda.gov/bbs/topics/ANSWERS/ANS01011.html. Accessed July 29, 2007.
4. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity;Iyer;Pharmacogenomics J.,2002
5. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2;Humerickhouse;Cancer Res.,2000